Buy or sell Auris Health, Inc. stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Auris Health, Inc. Stock
Robotic endoscopy medical device company
About Auris Health, Inc. Stock
Auris Health develops robotics technology for endoscopy - a nonsurgical medical procedure used to examine a person's digestive tract. The Company currently has one offering: Monarch Platform. The Monarch Platform and its accessories are intended to provide bronchoscopic visualization of and access to patient airways for diagnostic and therapeutic procedures. According to the company, its Monarch Platform improves upon existing minimally invasive techniques by integrating robotics, micro-instrumentation, endoscope design, sensing, and data science into one platform to enable new categories of care. The Company states that lung cancer is the first disease it is targeting.
Auris had been in "stealth" for nearly a decade, but in March 2018, it attained FDA approval for its Monarch Platform to be used for "bronchoscopic procedures," such as diagnosing lung cancer.
The Company was incorporated in 2007 and is based in the San Francisco Bay area.
Bronchoscopy Overview:
Source: Crunchbase; Auris
Investors
Highland Capital Partners
Scopely, Auris Health, Inc., Welltok, Rent the Runway, Enjoy, Qumulo, EverlyWell, Carbon Black, Turbonomic, Tomorrow.io
Lux Capital
Anduril Industries, Relativity Space, Auris Health, Inc., Carbon Health, Anchorage Digital, Flutterwave, Desktop Metal, Benchling, Aurora Solar, Ironclad
Mithril Capital Management
Palantir Technologies, Auris Health, Inc., C2FO, AppDirect, Lookout, Figure, Spaceflight Industries, GreyOrange, Stem, DoubleDutch
NaviMed Capital
Funding History
| May 2009 | $1.6M |
|---|---|
| June 2011 | $9.7M |
| August 2012 | $1.4M |
| March 2014 | $33.0M |
| September 2015 | $208M |
| June 2017 | $280M |
| November 2018 | $220M |
Management
Co-Founder & CEO
Fred Moll
Chief Strategy Officer
Josh DeFonzo
CFO
David Styka
VP of Operations
Dan Bradford
VP of Sales
Eric Davidson
VP of Engineering
Richard Leparmentier
VP of R&D
David Mintz
VP of Business Development
David Schummers
Press
Xconomy - Nov, 28 2018
The FentonPost - Sep, 15 2018
Newszak (blog) - Sep, 8 2018
The City Chronicle - Aug, 28 2018
theperfectinvestor.com - Jun, 19 2018
Mass Device - May, 22 2018
Mass Device - May, 16 2018
TechCrunch - Mar, 24 2018
FierceBiotech - Mar, 23 2018
BusinessWire - Mar, 23 2018
TechCrunch - Aug, 4 2017
MilTech - May, 3 2017
Med Device Online (press release) - Dec, 15 2016
Mass Device - Jul, 28 2016
Med Device Online (press release) - Jun, 10 2016
massdevice - Jan, 22 2016
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
